A citation-based method for searching scientific literature

John M Boyle, Kelsey M Hennick, Samuel G Regalado, Jacob M Vogan, Xiaozhu Zhang, Kathleen Collins, Dirk Hockemeyer. Mol Biol Cell 2020
Times Cited: 2







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
194
100

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
100

Telomeres: history, health, and hallmarks of aging.
Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho. Cell 2021
18
100

TINF2 is a haploinsufficient tumor suppressor that limits telomere length.
Isabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai, Maaike Haadsma, Liesbeth Spruijt, Richarda M de Voer, Seunga Sara Choo, Franziska K Lorbeer, Emma J van Grinsven, Dirk Hockemeyer,[...]. Elife 2020
3
100

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
272
100

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
127
100

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
214
100

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
100

The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
475
100

The telosome/shelterin complex and its functions.
Huawei Xin, Dan Liu, Zhou Songyang. Genome Biol 2008
121
50

Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation.
Alec N Sexton, Samuel G Regalado, Christine S Lai, Gregory J Cost, Colleen M O'Neil, Fyodor D Urnov, Philip D Gregory, Rudolf Jaenisch, Kathleen Collins, Dirk Hockemeyer. Genes Dev 2014
76
50

Telomere protection by TPP1/POT1 requires tethering to TIN2.
Kaori K Takai, Tatsuya Kibe, Jill R Donigian, David Frescas, Titia de Lange. Mol Cell 2011
141
50

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
Dirk Hockemeyer, Frank Soldner, Caroline Beard, Qing Gao, Maisam Mitalipova, Russell C DeKelver, George E Katibah, Ranier Amora, Elizabeth A Boydston, Bryan Zeitler,[...]. Nat Biotechnol 2009
724
50


Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Thet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, Jan Rowson, Guy Pratt, Saman Hewamana, Chris Fegan, Chris Pepper, Duncan M Baird. Blood 2010
116
50

Telomere fusions associate with coding sequence and copy number alterations in CLL.
Laura Escudero, Kez Cleal, Kevin Ashelford, Chris Fegan, Chris Pepper, Kate Liddiard, Duncan M Baird. Leukemia 2019
5
50

Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
Alexandra M Pinzaru, Robert A Hom, Angela Beal, Aaron F Phillips, Eric Ni, Timothy Cardozo, Nidhi Nair, Jaehyuk Choi, Deborah S Wuttke, Agnel Sfeir,[...]. Cell Rep 2016
60
50

Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
P Gu, Y Wang, K K Bisht, L Wu, L Kukova, E M Smith, Y Xiao, S M Bailey, M Lei, J Nandakumar,[...]. Oncogene 2017
29
50

Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer.
Cong Chen, Peili Gu, Jian Wu, Xianyun Chen, Shuangshuang Niu, Hong Sun, Lijie Wu, Na Li, Junhui Peng, Shaohua Shi,[...]. Nat Commun 2017
42
50

Telomerase activity in melanocytic lesions: A potential marker of tumor biology.
P Rudolph, C Schubert, S Tamm, K Heidorn, A Hauschild, I Michalska, S Majewski, G Krupp, S Jablonska, R Parwaresch. Am J Pathol 2000
59
50

Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
Dirk Hockemeyer, Jan-Peter Daniels, Hiroyuki Takai, Titia de Lange. Cell 2006
279
50

TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.
Huawei Xin, Dan Liu, Ma Wan, Amin Safari, Hyeung Kim, Wen Sun, Matthew S O'Connor, Zhou Songyang. Nature 2007
358
50

Analyzing CRISPR genome-editing experiments with CRISPResso.
Luca Pinello, Matthew C Canver, Megan D Hoban, Stuart H Orkin, Donald B Kohn, Daniel E Bauer, Guo-Cheng Yuan. Nat Biotechnol 2016
213
50

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
S E Artandi, S Chang, S L Lee, S Alson, G J Gottlieb, L Chin, R A DePinho. Nature 2000
838
50

Long telomeres and cancer risk among 95 568 individuals from the general population.
Line Rode, Børge G Nordestgaard, Stig E Bojesen. Int J Epidemiol 2016
52
50

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
Göran Roos, Alexander Kröber, Pawel Grabowski, Dirk Kienle, Andreas Bühler, Hartmut Döhner, Richard Rosenquist, Stephan Stilgenbauer. Blood 2008
97
50

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Helen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, Martin J S Dyer, Amy Holroyd, Yufei Wang, Nicola J Sunter, Larry Mansouri, Gunnar Juliusson, Karin E Smedby,[...]. Nat Genet 2014
122
50

Structural and functional analysis of the human POT1-TPP1 telomeric complex.
Cory Rice, Prashanth Krishna Shastrula, Andrew V Kossenkov, Robert Hills, Duncan M Baird, Louise C Showe, Tzanko Doukov, Susan Janicki, Emmanuel Skordalakes. Nat Commun 2017
47
50

Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
R A Greenberg, L Chin, A Femino, K H Lee, G J Gottlieb, R H Singer, C W Greider, R A DePinho. Cell 1999
307
50

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.
Frank Soldner, Dirk Hockemeyer, Caroline Beard, Qing Gao, George W Bell, Elizabeth G Cook, Gunnar Hargus, Alexandra Blak, Oliver Cooper, Maisam Mitalipova,[...]. Cell 2009
50

The POT1-TPP1 telomere complex is a telomerase processivity factor.
Feng Wang, Elaine R Podell, Arthur J Zaug, Yuting Yang, Paul Baciu, Thomas R Cech, Ming Lei. Nature 2007
462
50

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.
D Rossi, C Lobetti Bodoni, E Genuardi, L Monitillo, D Drandi, M Cerri, C Deambrogi, I Ricca, A Rocci, S Ferrero,[...]. Leukemia 2009
76
50

POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.
Dirk Hockemeyer, Agnel J Sfeir, Jerry W Shay, Woodring E Wright, Titia de Lange. EMBO J 2005
215
50

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
K A Kolquist, L W Ellisen, C M Counter, M Meyerson, L K Tan, R A Weinberg, D A Haber, W L Gerald. Nat Genet 1998
349
50

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.
Jayakrishnan Nandakumar, Caitlin F Bell, Ina Weidenfeld, Arthur J Zaug, Leslie A Leinwand, Thomas R Cech. Nature 2012
202
50

Hypervariable ultra-long telomeres in mice.
D Kipling, H J Cooke. Nature 1990
481
50

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Rajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Cristina Sison, Steven L Allen, Jonathan Kolitz, Vincent P Vinciguerra, Prasad Kudalkar,[...]. Blood 2004
131
50

Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
Mark A DeWitt, Wendy Magis, Nicolas L Bray, Tianjiao Wang, Jennifer R Berman, Fabrizia Urbinati, Seok-Jin Heo, Therese Mitros, Denise P Muñoz, Dario Boffelli,[...]. Sci Transl Med 2016
229
50

Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
Brian E McIntosh, Matthew E Brown, Bret M Duffin, John P Maufort, David T Vereide, Igor I Slukvin, James A Thomson. Stem Cell Reports 2015
95
50

Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Won-Tae Kim, Kelsey Hennick, Joshua Johnson, Brendan Finnerty, Seunga Choo, Sarah B Short, Casey Drubin, Ryan Forster, Mary L McMaster, Dirk Hockemeyer. EMBO J 2021
2
50

Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.
Russell C DeKelver, Vivian M Choi, Erica A Moehle, David E Paschon, Dirk Hockemeyer, Sebastiaan H Meijsing, Yasemin Sancak, Xiaoxia Cui, Eveline J Steine, Jeffrey C Miller,[...]. Genome Res 2010
211
50

DNA damage foci at dysfunctional telomeres.
Hiroyuki Takai, Agata Smogorzewska, Titia de Lange. Curr Biol 2003
973
50

Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.
Christopher J Lengner, Alexander A Gimelbrant, Jennifer A Erwin, Albert Wu Cheng, Matthew G Guenther, G Grant Welstead, Raaji Alagappan, Garrett M Frampton, Ping Xu, Julien Muffat,[...]. Cell 2010
270
50

Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
Marie-Catherine Giarratana, Ladan Kobari, Hélène Lapillonne, David Chalmers, Laurent Kiger, Thérèse Cynober, Michael C Marden, Henri Wajcman, Luc Douay. Nat Biotechnol 2005
367
50

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.
Angelo Lombardo, Pietro Genovese, Christian M Beausejour, Silvia Colleoni, Ya-Li Lee, Kenneth A Kim, Dale Ando, Fyodor D Urnov, Cesare Galli, Philip D Gregory,[...]. Nat Biotechnol 2007
619
50


A DNA damage checkpoint response in telomere-initiated senescence.
Fabrizio d'Adda di Fagagna, Philip M Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas Von Zglinicki, Gabriele Saretzki, Nigel P Carter, Stephen P Jackson. Nature 2003
50


POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex.
Jeffrey Zheng-Sheng Ye, Dirk Hockemeyer, Andrew N Krutchinsky, Diego Loayza, Sarah M Hooper, Brian T Chait, Titia de Lange. Genes Dev 2004
318
50

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
Andrew J Ramsay, Víctor Quesada, Miguel Foronda, Laura Conde, Alejandra Martínez-Trillos, Neus Villamor, David Rodríguez, Agnieszka Kwarciak, Cecilia Garabaya, Mercedes Gallardo,[...]. Nat Genet 2013
182
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.